Scheltens P, De Strooper B, Kivipelto MHH, Chetelat G, Teunissen CE, et al. Alzheimer's disease. Lancet. 2021;S0140-6736(20):32205-4.

Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 2018;14(4):535–62.

Article  PubMed  Google Scholar 

DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer’s disease. Mol Neurodegener. 2019;14(1):32.

Article  PubMed  PubMed Central  Google Scholar 

James BD, Wilson RS, Boyle PA, Trojanowski JQ, Bennett DA, Schneider JA. TDP-43 stage, mixed pathologies, and clinical Alzheimer’s-type dementia. Brain. 2016;139(11):2983–93.

Article  PubMed  PubMed Central  Google Scholar 

Twohig D, Nielsen HM. Alpha-synuclein in the pathophysiology of Alzheimer’s disease. Mol Neurodegener. 2019;14(1):23.

Article  PubMed  PubMed Central  Google Scholar 

Martens YA, Zhao N, Liu CC, Kanekiyo T, Yang AJ, Goate AM, et al. ApoE Cascade Hypothesis in the pathogenesis of Alzheimer’s disease and related dementias. Neuron. 2022;110(8):1304–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Howell JC, Watts KD, Parker MW, Wu J, Kollhoff A, Wingo TS, et al. Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers. Alzheimers Res Ther. 2017;9(1):88.

Article  PubMed  PubMed Central  Google Scholar 

Tsiknia AA, Edland SD, Sundermann EE, Reas ET, Brewer JB, Galasko D, et al. Sex differences in plasma p-tau181 associations with Alzheimer’s disease biomarkers, cognitive decline, and clinical progression. Mol Psychiatry. 2022;27(10):4314–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Refolo LM, Snyder H, Liggins C, Ryan L, Silverberg N, Petanceska S, et al. Common Alzheimer’s disease research ontology: National Institute on Aging and Alzheimer’s Association collaborative project. Alzheimers Dement. 2012;8(4):372–5.

Article  PubMed  Google Scholar 

Alzheimer’s Association. Revised Criteria for Diagnosis and Staging of Alzheimer’s Disease. Alzheimer’s Association Workgroup. 2024. https://aaic.alz.org/diagnostic-criteria.asp. Cited 1 Jan 2024.

Salvado G, Horie K, Barthelemy NR, Vogel JW, Pichet Binette A, Chen CD, et al. Disease staging of Alzheimer's disease using a CSF-based biomarker model. Nat Aging. 2024.

Therriault J, Schindler SE, Salvado G, Pascoal TA, Benedet AL, Ashton NJ, et al. Biomarker-based staging of Alzheimer disease: rationale and clinical applications. Nat Rev Neurol. 2024;20(4):232–44.

Article  PubMed  Google Scholar 

Lo RY, Hubbard AE, Shaw LM, Trojanowski JQ, Petersen RC, Aisen PS, et al. Longitudinal change of biomarkers in cognitive decline. Arch Neurol. 2011;68(10):1257–66.

Article  PubMed  PubMed Central  Google Scholar 

Cummings J, Zhou Y, Lee G, Zhong K, Fonseca JFC. Alzheimer's disease drug development pipeline: 2024. Alzheimers Dement. 2024 (Ahead of print).

Reiman EM, Cummings JL, Langbaum JB, Mattke S, Alexander RC. A chance to prevent Alzheimer’s disease sooner than you think. Lancet Neurol. 2024;23(2):144–5.

Article  PubMed  Google Scholar 

Barbera M, Lehtisalo J, Perera D, Aspo M, Cross M, De Jager Loots CA, et al. A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol. Alzheimers Res Ther. 2024;16(1):23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rezai AR, D’Haese PF, Finomore V, Carpenter J, Ranjan M, Wilhelmsen K, et al. Ultrasound blood-brain barrier opening and aducanumab in Alzheimer’s disease. N Engl J Med. 2024;390(1):55–62.

Article  CAS  PubMed  Google Scholar 

Niewoehner J, Bohrmann B, Collin L, Urich E, Sade H, Maier P, et al. Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle. Neuron. 2014;81(1):49–60.

Article  CAS  PubMed  Google Scholar 

Piazza F, Caminiti SP, Zedde M, Presotto L, DiFrancesco JC, Pascarella R, et al. Association of microglial activation with spontaneous ARIA-E and CSF levels of anti-abeta autoantibodies. Neurology. 2022;99(12):e1265–77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Food and Drug Administration. Guidance for Industry. Co-development of two or more new investigational drug for use in combination. U.S. Department of Health and Human services, Food and Drug administration, Center for Drug Evaluation and Research (CDER). Silver Springs, Maryland; 2013.

Pioro EP, Brooks BR, Cummings J, Schiffer R, Thisted RA, Wynn D, et al. Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect. Ann Neurol. 2010;68(5):693–702.

Article  CAS  PubMed  Google Scholar 

Ward K, Citrome L. AXS-05: an investigational treatment for Alzheimer’s disease-associated agitation. Expert Opin Investig Drugs. 2022;31(8):773–80.

Article  CAS  PubMed  Google Scholar 

Breier A, Brannan SK, Paul SM, Miller AC. Evidence of trospium’s ability to mitigate cholinergic adverse events related to xanomeline: Phase 1 study results. Psychopharmacology. 2023;240(5):1191–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grimm HP, Schumacher V, Schafer M, Imhof-Jung S, Freskgard PO, Brady K, et al. Delivery of the Brainshuttle amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans. MAbs. 2023;15(1):2261509.

Article  PubMed  PubMed Central  Google Scholar 

Nordvall G, Lundkvist J, Sandin J. Gamma-secretase modulators: a promising route for the treatment of Alzheimer’s disease. Front Mol Neurosci. 2023;16:1279740.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Food and Drug administration. Guidance for industry: codevelopment of two or more unmarketed investigational drugs for use in combination. U.S. Department of Health and Human Services, Food and Drug Administration, Centers for Drug Evaluation and Research (CDER). Silver Springs, Maryland; 2010.

Food and Drug Administration. Master protocols: efficient clinical design strategies to expedite development of oncology drugs and biologics. Guidance for Industry. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Oncology Center of Excellence (OCE). Silver Springs, Maryland; 2022.

Cummings J, Montes A, Kamboj S, Cacho JF. The role of basket trials in drug development for neurodegenerative disorders. Alzheimers Res Ther. 2022;14(1):73.

Article  PubMed  PubMed Central  Google Scholar 

Brooks BR, Thisted RA, Appel SH, Bradley WG, Olney RK, Berg JE, et al. Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology. 2004;63(8):1364–70.

Article  CAS  PubMed  Google Scholar 

Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I, et al. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA. 2004;291(3):317–24.

Article  CAS  PubMed  Google Scholar 

Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ, et al. Memantine in moderate-to-severe Alzheimer’s disease. N Engl J Med. 2003;348(14):1333–41.

Article  CAS  PubMed  Google Scholar 

Cummings J, Osse AML, Cammann D, Powell J, Chen J. Anti-amyloid monoclonal antibodies for the treatment of Alzheimer’s disease. BioDrugs. 2024;38(1):5–22.

Article  CAS  PubMed  Google Scholar 

Mintun MA, Lo AC, Duggan Evans C, Wessels AM, Ardayfio PA, Andersen SW, et al. Donanemab in early Alzheimer’s disease. N Engl J Med. 2021;384(18):1691–704.

Article  CAS  PubMed  Google Scholar 

Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, et al. Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023;330(6):512–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Budd Haeberlein S, Aisen PS, Barkhof F, Chalkias S, Chen T, Cohen S, et al. Two randomized Phase 3 studies of aducanumab in early Alzheimer’s disease. J Prev Alzheimers Dis. 2022;9(2):197–210.

CAS  PubMed  Googl